Bayer wins US FDA approval for Sunharbo to reduce repeat strokes
Detailed summary
The US Food and Drug Administration on Monday approved a new type of blood thinner developed by Bayer for the prevention of strokes in patients who have alre ...
Sunharbo is approved as a once-daily treatment to prevent another stroke in patients whose previous stroke was not caused by a clot from the heart.
The drug, which has the chemical name asundexian and will be sold under the brand name Sunharbo, is the first approved treatment designed to prevent harmful blood clots by blocking the clotting protein Factor XIa. (Representational image: Unsplash)
Opening of the article, excerpted from Emirates 24/7. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.emirates247.com)
